Heron Therapeutics, Inc.

HRTXNASDAQHealthcare● Active

$0.45

$-0.00(-0.26%)

Market Cap$71452015

P/E Ratio—

52W High$2.3

52W Low$0.42

Avg Volume2.6M

Open$0.46

Beta1.57

Overview

Heron Therapeutics, Inc. (HRTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · HRTX · as of Feb 26, 2026

Latest filing snapshot

128

+6+4.92%vs prior year

Heron Therapeutics, Inc. (HRTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

128

Change (1Y)

Growth % (1Y)

+4.92%

Revenue / Employee

$1.21M

Net Income / Employee

$-157.8K

Market Cap

$72M

HRTX Employee Count

1995 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	128	+6	+4.92%
2025-02-27	2024-12-31	122	-4	-3.17%
2024-03-12	2023-12-31	126	-77	-37.93%
2023-03-29	2022-12-31	203	-99	-32.78%
2022-02-28	2021-12-31	302	+79	+35.43%
2021-02-24	2020-12-31	223	-8	-3.46%
2020-03-02	2019-12-31	231	+33	+16.67%
2019-02-22	2018-12-31	198	+53	+36.55%
2018-02-27	2017-12-31	145	+6	+4.32%
2017-02-23	2016-12-31	139	-9	-6.08%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CHRS

Coherus Oncology, Inc.

Heron Therapeutics, Inc.YOU

Eupraxia Pharmaceuticals Inc.

33$208M #7

NTHI

Neonc Technologies Holdings, Inc.

8$91M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · HRTX peer comparison

About HRTX employees

HRTX Employees · Headcount

Heron Therapeutics, Inc. (HRTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Heron Therapeutics, Inc. had 128 full-time employees globally. Full-time employees only. Global consolidated headcount.

Heron Therapeutics, Inc. employs 128 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.21M, reflecting the company's operational efficiency.

Heron Therapeutics, Inc.'s workforce increased by 6 (4.92%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Heron Therapeutics, Inc.'s revenue per employee of $1.21M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

HRTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Heron Therapeutics, Inc. had 128 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Heron Therapeutics, Inc. employee counthow many employees does Heron Therapeutics, Inc. haveHRTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26